Moderna, Inc. (MRNA) FY2026 Q2 Balance Sheet

Income StatementCash FlowBalance Sheet

Balance Sheet

As of 2026-06-30

Swipe to see the full flow
Moderna, Inc. (MRNA) FY2026 Q2 Balance SheetBalance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.Current liabilities$2.53 BLiabilities$4.20 BCurrent assets$5.82 BAssets$10.96 BNon-current liabilities$1.67 BNon-current assets$5.15 BEquity$6.76 BHOLDINGSASSET CLASSASSETSCLAIM CLASSCLAIM SUB-CLASSCLAIMSInvestmentsCash and cash equivalentsPrepaid expenses and other current assetsInventoryAccounts receivable, netProperty, plant and equipment, netInvestments, non-currentRight-of-use assets, operating leasesOther non-current assetsAccrued liabilitiesDeferred revenueAccounts payableOther current liabilitiesOperating lease liabilities, non-currentLong-term debtOther non-current liabilitiesDeferred revenue, non-currentFinancing lease liabilities, non-currentRetained earningsAdditional paid-in capitalAccumulated other comprehensive incomeCurrent assetsNon-current assetsAssetsCurrent liabilitiesNon-current liabilitiesLiabilitiesEquityCurrent liabilitiesCurrent liabilities$2.53 BAccrued liabilitiesAccrued liabilities$1.91 BDeferred revenueDeferred revenue$295.00 MLiabilitiesLiabilities$4.20 BCurrent assetsCurrent assets$5.82 BAccounts payableAccounts payable$167.00 MInvestmentsInvestments$3.42 BAssetsAssets$10.96 BOther current liabilitiesOther current liabilities$163.00 MCash and cash equivalentsCash and cash equivalents$1.72 BOperating lease liabilities, non-currentOperating lease liabilities, non-current$638.00 MNon-current liabilitiesNon-current liabilities$1.67 BPrepaid expenses and other current assetsPrepaid expenses and other current assets$380.00 MLong-term debtLong-term debt$591.00 MInventoryInventory$280.00 MOther non-current liabilitiesOther non-current liabilities$284.00 MDeferred revenue, non-currentDeferred revenue, non-current$147.00 MAccounts receivable, netAccounts receivable, net$17.00 MNon-current assetsNon-current assets$5.15 BFinancing lease liabilities, non-currentFinancing lease liabilities, non-current$6.00 MEquityEquity$6.76 BProperty, plant and equipment, netProperty, plant and equipment, net$2.06 BInvestments, non-currentInvestments, non-current$1.77 BRetained earningsRetained earnings$5.10 BRight-of-use assets, operating leasesRight-of-use assets, operating leases$697.00 MOther non-current assetsOther non-current assets$618.00 MAdditional paid-in capitalAdditional paid-in capital$1.64 BAccumulated other comprehensive incomeAccumulated other comprehensive income$19.00 M
Chart details

Moderna, Inc. (MRNA) FY2026 Q2 Balance Sheet

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

Assets
10,961,000,000 US dollars
Current assets
5,815,000,000 US dollars
Non-current assets
5,146,000,000 US dollars
Liabilities
4,200,000,000 US dollars
Current liabilities
2,534,000,000 US dollars
Non-current liabilities
1,666,000,000 US dollars
Equity
6,761,000,000 US dollars
Investments
3,415,000,000 US dollars
Cash and cash equivalents
1,723,000,000 US dollars
Prepaid expenses and other current assets
380,000,000 US dollars
Inventory
280,000,000 US dollars
Accounts receivable, net
17,000,000 US dollars
Property, plant and equipment, net
2,059,000,000 US dollars
Investments, non-current
1,772,000,000 US dollars
Right-of-use assets, operating leases
697,000,000 US dollars
Other non-current assets
618,000,000 US dollars
Accrued liabilities
1,909,000,000 US dollars
Deferred revenue
295,000,000 US dollars
Accounts payable
167,000,000 US dollars
Other current liabilities
163,000,000 US dollars
Operating lease liabilities, non-current
638,000,000 US dollars
Long-term debt
591,000,000 US dollars
Other non-current liabilities
284,000,000 US dollars
Deferred revenue, non-current
147,000,000 US dollars
Financing lease liabilities, non-current
6,000,000 US dollars
Retained earnings
5,098,000,000 US dollars
Additional paid-in capital
1,644,000,000 US dollars
Accumulated other comprehensive income
19,000,000 US dollars
Preferred stock, par value $0.0001; 162 shares authorized as of June 30, 2026 and December 31, 2025; no shares issued or outstanding at June 30, 2026 and December 31, 2025
0 US dollars
Common stock, par value $0.0001; 1,600 shares authorized as of June 30, 2026 and December 31, 2025; 399 and 394 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively
0 US dollars

Chart connections

  • Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
  • Treasury shares and other negative equity contributions reduce equity.
Moderna, Inc. (MRNA) FY2026 Q2 Balance Sheet Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!